Abstract
IgG4‐related retroperitoneal fibrosis is rare but eminently treatable. Here the authors discuss recently published classification criteria and how the disease is managed, including maintenance therapy once patients are in remission.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
